physIQ Heart Rhythm and Respiratory Module vs PMcardio
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Both physIQ Heart Rhythm and Respiratory Module and PMcardio are AI-powered cardiology tools, but they differ in their primary data input and focus. physIQ specializes in continuous wearable biosensor data for personalized physiological analytics and early decompensation detection, while PMcardio focuses on rapid, expert-level interpretation of single-point ECGs for diagnosing over 50 cardiac conditions. Therefore, physIQ is better suited for continuous monitoring and trend analysis, whereas PMcardio excels in immediate diagnostic support based on ECG readings.
Choose physIQ Heart Rhythm and Respiratory Module if…
Choose physIQ Heart Rhythm and Respiratory Module if your primary need is continuous, long-term remote patient monitoring using wearable biosensor data to detect subtle physiological changes and early signs of decompensation. This tool excels at establishing a personalized physiological baseline for each patient and identifying deviations in heart rhythm (including atrial fibrillation) and respiration rate over time, making it ideal for managing chronic conditions or post-acute care.
View physIQ Heart Rhythm and Respiratory Module →Choose PMcardio if…
Choose PMcardio if you require rapid and highly accurate AI-powered interpretation of standard 12-lead ECGs in a clinical or emergency setting. This tool is best suited for quickly identifying a broad spectrum of common cardiac abnormalities, including STEMI/OMI, rhythms, and reduced LVEF, providing comprehensive diagnostic support and guideline-adherent treatment recommendations at the point of care.
View PMcardio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | physIQ Heart Rhythm and Respiratory Module | PMcardio |
|---|---|---|
| Pricing | Contact for pricing | Freemium |
| Deployment | Cloud-based platform | Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems |
| FDA Status | 1 AI-estimated | Pending AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | physIQ Heart Rhythm and Respiratory Module | PMcardio |
|---|---|---|
| Tool Name | physIQ Heart Rhythm and Respiratory Module | PMcardio |
| Company | physIQ | Powerful Medical |
| Tagline | The leader in digital medicine, dedicated to generating unprecedented health insight using continuous wearable biosensor data and advanced analytics. | AI that reads ECGs in seconds |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Clinical Decision Support & Reference |
| Key Features (Cardiology-focused) | Calculates heart rate and heart rate variability, Detects atrial fibrillation | Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies), Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization |
Videos
Demos, reviews, and walkthroughs featuring physIQ Heart Rhythm and Respiratory Module and PMcardio.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
physIQ Heart Rhythm and Respiratory Module is a cloud-based platform that continuously collects and processes data from wearable biosensors, implying integration would involve data ingestion from these devices into the platform and then potentially into the EHR. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, and its PDF reports can be exported and integrated into patient electronic health records.
physIQ's module focuses on AI-based personalized physiology analytics, detecting subtle physiological changes, early signs of decompensation, calculating heart rate and heart rate variability, and detecting atrial fibrillation using continuous wearable biosensor data. PMcardio provides instant AI-powered ECG interpretations, detecting over 50 cardiac conditions including STEMI/OMI and reduced LVEF, and offers visual AI explainability with heatmaps.
physIQ, with its continuous wearable biosensor data, is well-suited for cardiology, critical care, and pulmonology, particularly for remote patient monitoring and detecting subtle changes over time. PMcardio, interpreting 12-lead ECGs, is ideal for cardiology, emergency medicine, and internal medicine, where rapid, expert-level ECG interpretation is crucial at the point of care.
While not explicitly stated, PMcardio's mobile app and web platform, designed for rapid interpretation, suggest a potentially lower learning curve for individual use, though enterprise deployment would involve integration and training. physIQ's platform, focused on continuous data and advanced analytics, might require a more in-depth understanding of personalized physiology and data interpretation.
PMcardio for Organizations offers visibility into cardiac pathways, allowing tracking of performance, variation, and outcomes across deployed suites, which can be used for QA workflows and audit trails. PMcardio also provides professional ECG diagnostic reporting in PDF format that can be exported. physIQ's description highlights its advanced analytics and FDA-cleared digital biomarkers, suggesting a robust data trail, but specific audit trail features are not detailed.
PMcardio for Organizations is purpose-built for multi-pathway, multi-site cardiac care delivery, offering interoperability, decision support, escalation, outcomes intelligence, and governance in one platform. physIQ's enterprise-ready cloud platform and its application in clinical trials across multiple therapeutic areas suggest scalability for multi-site deployments, but specific features for multi-site management are not detailed.